Loading clinical trials...
Loading clinical trials...
This is a phase 3, multicenter, open-label, randomized active-controlled, parallel group to investigate the efficacy, safety and tolerability, and pharmacokinetics of intravenous murepavadin combined ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Polyphor Ltd.
NCT00001352 · Cryptococcal Infection, Cryptococcal Pneumonia, and more
NCT07388680 · Radiation-induced Lung Injury, Immune-related Pneumonia
NCT07428759 · Pneumonia, Bacterial
NCT05041140 · Pulmonary, Pneumonia, and more
NCT06743529 · Ventilator-Associated Pneumonia (VAP)
Research site
Chicago, Illinois
Research site
Springfield, Missouri
Research site
Greensboro, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions